Strategies to Reduce Weight Gain in Hypertensive Smokers
Weight Gain Prevention in Hypertensive Smokers
Weight Gain Prevention in Hypertensive Smokers
Sponsor study identifier
Secondary identifiers
NIH
interventional
459
0 countries
N/A
Study Start
September 2004
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
May 2011
Actual (reported)Study Completion
June 2011
Actual (reported)To evaluate the effectiveness of lifestyle modification following a smoking cessation program in preventing weight gain among hypertensive smokers placed at medical risk by the post-cessation weight gain.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2011
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2004
Date type not reportedThis date has not been verified as actual or estimated.
July 6, 2005
Actual (reported)July 14, 2005
Actual (reported)May 2011
Actual (reported)June 2011
Actual (reported)Smoking cessation rates
Measured at 1 year
Body weight changes
Measured at 1 year
Changes in dietary intake
Measured at 1 year
Changes in physical activity
Measured at 1 year
Changes in blood pressure and hypertensive status
Measured at 1 year
Changes in blood pressure medication status
Measured at 1 year
Changes in salt intake
Measured at 1 year
Behavioral Weight Reduction
Exercise
Smoking Cessation
Behavioral intervention
Moderate exercise implemented plus behavioral intervention.
Robert C. Klesges, PhD
University of Tennessee Center for Health Sciences
459 participants (actual enrollment reported by the registry).
First Submitted
July 6, 2005
First Posted
July 14, 2005
Study Start
September 2004
Date type not reportedThis date has not been verified as actual or estimated.
Effect of Exercise on Elevated C-reactive Protein Concentrations in Formerly Inactive Adults
Nicotine Patch in dosages given based on number of cigarettes per day smoked. 21 mg patch, 14 mg patch, 7 mg patch for total of 6 weeks duration of therapy. NRT gum is being provided to assist with relapse prevention. At the randomization visit the participant is given one (1) box of 2mg NRT gum, which consists of (110) pieces. The participant may request up to two (2) more boxes, for a maximum of three (3) boxes per participant.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
May 2011
Actual (reported)Study Completion
June 2011
Actual (reported)Last Updated
December 2, 2015
Record last verified: 2011-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: